Return to homepagePandemic Pact

Synthesis of antiviral natural products and derivatives

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: 2763179

Grant search

Key facts

  • Disease

    COVID-19, Disease X

  • Start & end year

    2022
    2026

  • Known Financial Commitments (USD)

    $0

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    N/A

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Nottingham

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The project will develop novel natural product-derived antiviral molecules to treat viral diseases such as SARS-Cov-2 (COVID-19) and influenza A (Seasonal flu). This timely and exciting project is a collaboration between researchers based in the Schools of Chemistry, Veterinary Medicine & Science and Pharmacy at University of Nottingham. This project will provide experience of multi-step synthetic organic chemistry and its application to the synthesis of biologically active molecules and/or natural products. New molecules will be tested for biological activity by our project partners, and the leading compounds will be selected for further development into a new class antiviral drugs.